Peptide Insight

Peptide Insights is a dedicated space for research-focused articles, scientific perspectives, and peptide-related updates. Here you'll find curated content covering laboratory research, emerging topics, industry developments, and broader scientific discussions relevant to peptides and associated compounds. The section is designed to present informative content in a clear, professional, and accessible format.

Hepcludex Approval: What Bulevirtide Means for Peptide Medicine

Science & Medicine Hepatitis D Entry Inhibitors Bulevirtide Regulatory Science Report The Gatekeeper Peptide: Why Hepcludex Approval Matters Beyond Hepatitis D On May 22, 2026, the FDA approved Hepcludex (bulevirtide) for chronic hepatitis delta — the first U…

Antifungal Peptides: Pipeline Against Silent Superbugs

Science & Medicine Antifungal Peptides Drug Resistance Candida auris Investigative Science Report Antifungal Peptides Against the Superbugs Nobody Talks About — A New Review Lays Out the Pipeline A May 2026 review in Frontiers in Microbiology argues that anti…

MOTS-c, Humanin, and the MDP Family | Ordinary Peptides

Science & Medicine Mitochondria Aging Research Cellular Biology Investigative Science Journalism The Mitochondrial Genome's Hidden Library: How a Forgotten Stretch of DNA Became the Hottest Frontier in Aging Research For most of the twentieth century, biologi…

The GHK-Cu Story: 1973 to 2026 | Ordinary Peptides

Wellness & Industry Cosmetic Science History Regulation Investigative Business / Science Journalism The Strangest Comeback in Cosmetic Science: How a Forgotten 1973 Discovery Became a $400M Industry Loren Pickart isolated a copper-binding tripeptide from huma…

The GLOW Marketing Playbook | Ordinary Peptides

Wellness & Industry Marketing Regulation Business Investigative Business Journalism The GLOW Marketing Playbook: How a Peptide Blend Became a Brand Before the Science Caught Up A Pilates instructor in Los Angeles, a TikTok hashtag with millions of views, a pr…

The CJC-1295 Story: 2006 to 2026 | Ordinary Peptides

Wellness & Industry Pharmaceutical History Regulation Business Investigative Business / Medical History The 2006 Argentina Trial Death That Killed CJC-1295's Pharmaceutical Future and Created a Wellness Industry How one patient's death in a Buenos Aires Phase…

How KLOW Became the Default Wellness Stack

Wellness & Industry Adoption Med-Spa Telehealth Industry Adoption Narrative How KLOW Became the Default Wellness Peptide Stack in Eighteen Months In late 2022, almost nobody was selling it. By mid-2024, it was on the menu at functional medicine clinics, med-s…

Semaglutide Research: Mechanism, Evidence and Science

Science & Medicine Obesity Cardiovascular Pharmacology Investigative Science Report The Original: How Semaglutide Built the Evidence Base That Every Newer Drug Is Still Chasing In November 2023, semaglutide achieved what no obesity drug had ever achieved: a 2…

Tirzepatide Research: How the Dual Agonist Works

Science & Medicine Obesity Clinical Trials Pharmacology Investigative Science Report The Twincretin That Changed the Calculation: Tirzepatide, What It Does, and What It Can't Undo Tirzepatide outperformed semaglutide by 47% in relative weight loss in the firs…

Retatrutide: Triple Receptor Agonist Research Overview

Science & Medicine Obesity Clinical Trials Pharmacology Investigative Science Report Three Keys Instead of One: Retatrutide and the New Arithmetic of Obesity An obesity drug producing nearly 30% body weight loss in 68 weeks — more than most bariatric surgical…

The Zagreb Origin of BPC-157, and What Came After

Science & Medicine Peptides History Research Long-Form History From Gastric Juice to Forum Folklore: How Two Peptides Discovered Decades Apart Ended Up in the Same Vial A war-time Croatian lab. A 1960s NIH thymus project. A Marvel character. The strange origi…